Health Condition 1: E040- Nontoxic diffuse goiter Health Condition 2: E049- Nontoxic goiter, unspecified Health Condition 3: E042- Nontoxic multinodular goiter Health Condition 4: E041- Nontoxic single thyroid nodule Health Condition 5: E048- Other specified nontoxic goiter
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age above 18 years Benign or cytologically indeterminate lesions involving single lobe of size
Exclusion criteria
Exclusion criteria: Age below 18 yrs Refusal to give consent Patients not fit for general anaesthesia/ neck extension required for surgical positioning History of head and neck surgery and previous irradiation All thyroid lesions of size Ë? 5 cm or 40ml All malignant lesions of thyroid Evidence of active clinical hyperthyroidism or thyroiditis Substernal thyroidal extension of swelling
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| cosmetic outcome and post operative complicationsTimepoint: 2, 6 and 12 weeks after surgery | — |
Primary
| Measure | Time frame |
|---|---|
| Quality of life using SF-36 and thyroid specific questionaires at 2, 6 and 12 weeks post surgeryTimepoint: 2, 6 and 12 weeks post surgery | — |
Countries
India
Contacts
All India Institute of Medical Sciences (AIIMS)